Testing effectiveness (Phase 2)Ended earlyNCT00615160What this trial is testingPTK/ZK in Disseminated Malignant MelanomaWho this might be right forMelanoma Michael Weichenthal 9
Early research (Phase 1)Ended earlyNCT02012231What this trial is testingPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Who this might be right forMelanomaThyroid CancerColorectal Cancer+4 more Fore Biotherapeutics 5
Testing effectiveness (Phase 2)Study completedNCT03679767What this trial is testingINCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)Who this might be right forMetastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more Incyte Corporation 121
Testing effectiveness (Phase 2)Study completedNCT02902029What this trial is testingEvaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant MelanomaWho this might be right forMalignant Melanoma University Hospital, Essen 186
Testing effectiveness (Phase 2)Study completedNCT01164007What this trial is testingBevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 40
Early research (Phase 1)Ended earlyNCT03565406What this trial is testingA Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV MelanomaWho this might be right forMelanoma NYU Langone Health 11
Testing effectiveness (Phase 2)Study completedNCT00658437What this trial is testingCY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior TherapyWho this might be right forMelanoma Cytavis Biopharma GmbH 31
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Early research (Phase 1)Ended earlyNCT01409174What this trial is testingIPI Biochemotherapy for Chemonaive Patients With Metastatic MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00255762What this trial is testingCarboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaStage IV Melanoma National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Ended earlyNCT04527549What this trial is testingTesting Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K MelanomaWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more ECOG-ACRIN Cancer Research Group 5
Testing effectiveness (Phase 2)WithdrawnNCT05482074What this trial is testingOlaparib in Unresectable/Metastatic Melanoma With BRCA1/2Who this might be right forRecurrent Metastatic MelanomaCutaneous MelanomaMucosal Melanoma+1 more Dana-Farber Cancer Institute
Large-scale testing (Phase 3)Study completedNCT01689519What this trial is testingA Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 495
Testing effectiveness (Phase 2)Active Not RecruitingNCT04356729What this trial is testingA Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Stage IV MelanomaUnresectable Stage III Cutaneous Melanoma+1 more F. Stephen Hodi, MD 30
Testing effectiveness (Phase 2)Looking for participantsNCT06727630What this trial is testingA Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic MelanomaWho this might be right forMelanoma Zhuhai Yufan Biotechnologies Co., Ltd 40
Large-scale testing (Phase 3)Looking for participantsNCT06743126What this trial is testingSUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous MelanomaWho this might be right forMelanoma, Cutaneous Malignant Immatics US, Inc. 360
Early research (Phase 1)Study completedNCT02077114What this trial is testingVaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant MelanomaWho this might be right forMalignant Melanoma With Metastasis Herlev Hospital 10
Early research (Phase 1)Ended earlyNCT01557114What this trial is testingStudy of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant MelanomaWho this might be right forMalignant Melanoma Gustave Roussy, Cancer Campus, Grand Paris 19
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Ended earlyNCT00849875What this trial is testingSafety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma PatientsWho this might be right forMelanoma GlaxoSmithKline 48